RFK Jr's Autism Committee Reshuffle Ignites Controversy and Alternative Group Emergence
The first public meeting of the United States' revamped Interagency Autism Coordinating Committee (IACC) was abruptly cancelled recently, with minimal explanation provided. This development coincides with mounting concerns regarding the committee's new composition under Health and Human Services Secretary Robert F Kennedy Jr, a long-time proponent of the scientifically debunked link between vaccines and autism.
Committee Overhaul and Questionable Appointments
In late January, Kennedy appointed entirely new members to the IACC, significantly reducing autistic representation while incorporating several prominent anti-vaccine advocates. The committee, established in 2006 under the Combating Autism Act, plays a crucial role in advising on nearly $2 billion in federal autism research funding and making policy recommendations across various government sectors including housing, defense, education, and social services.
Former committee member Matt Carey described the newly constituted federal committee as a "sham," suggesting Kennedy may use it to legitimize flawed science. "It's like his ACIP," Carey stated, referencing Kennedy's similar overhaul of the Advisory Committee on Immunization Practices. "The IACC is selected to give him the answers he wants."
Dangerous Treatments and Scientific Concerns
Several of Kennedy's appointees have previously promoted dangerous and ineffective autism "treatments," including industrial bleach enemas, heavy-metal removal through chelation, and hyperbaric oxygen chambers. The Food and Drug Administration had previously warned against these methods on a webpage that has since been deleted.
Zoe Gross, director of advocacy at the Autistic Self Advocacy Network, expressed serious concerns that the federal committee might allocate funds to research long-discredited theories, particularly the vaccine-autism connection. "It's tantamount to setting money on fire – except worse than that, because not only will they be wasteful of government funds, they'll also be disastrous for public health," Gross emphasized.
Emergence of a Rival Committee
In response to growing apprehension about the federal committee's direction, a new organization called the Independent Autism Coordinating Committee (I-ACC) was announced on March 3. This pro-science group aims to provide research recommendations to private donors and institutions, positioning itself as a counterbalance to what experts perceive as the federal committee's misalignment with established scientific consensus.
However, the independent committee has also faced criticism for its own composition, featuring only one autistic member among its ranks. Some members have advocated for creating a separate "profound autism" category, an approach that many in the autistic community argue lacks scientific foundation.
Scientific Debate and Representation Issues
Steven Kapp, a senior lecturer in psychology at the University of Portsmouth who is autistic, noted that despite extensive efforts, "no independent research teams have been able to identify valid subtypes of autism." He described the conversation around "severe" or "profound" autism as primarily a policy discussion disguised as clinical debate.
The federal committee, by legal requirement, must include at least three autistic members. Prior to Kennedy's complete membership replacement, the committee had seven autistic public members and one autistic federal workforce member, including several people of color and women.
Conflicting Visions for Autism Research
HHS spokesperson Emily Hilliard stated that the federal committee would "fulfill President Trump's directive to bring autism research to the 21st century and support breakthroughs in autism diagnosis, treatment and prevention." The cancelled meeting has been postponed indefinitely, with further information to be shared when available.
Meanwhile, Alison Singer, president of the Autism Science Foundation which helped establish the independent committee, has described autism prevention as a "strong focus" for scientific research. This perspective conflicts with that of many autistic advocates who argue that autism doesn't require prevention but rather community inclusion and support.
Future Directions and Committee Evolution
David Mandell, professor of psychiatry at the University of Pennsylvania and a founding member of the independent committee, acknowledged that the group was assembled rapidly and needs to expand its representation. "One of the first items of business should be to ask who is represented and who is missing, and how can we increase and enhance our ranks so that all important perspectives are represented?" Mandell stated.
The independent committee plans to hold its first meeting coinciding with what would have been the federal committee's scheduled session. Mandell emphasized that the group's primary focus is establishing a rigorous research agenda based on evidence-based science, with hopes of influencing both private funders and future government administrations.
"The idea that we could proactively identify what a research agenda should look like in autism and present that to private funders, to the public, and hopefully have it ready for when there's a change in administration and another opportunity to fund high-quality science, that it will be ready then, too – that was very appealing," Mandell explained.
